Acral Melanoma

• CLINICAL_TRIALS trial_result · 2026-04-02
  Clinical Trial Update: Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma [Phase 1]

  Phase 1 trial update reports proof of concept for TBio-4101 in combination with lymphodepleting chemotherapy and IL-2 for relapsed/refractor…

• CLINICAL_TRIALS trial_result · 2025-04-02
  Clinical Trial Update: Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor [Phase 2]

  A Phase 2 trial evaluating the combination of Vactosertib and Pembrolizumab in acral and mucosal melanoma patients who progressed on prior i…

• CLINICAL_TRIALS trial_result · 2023-09-06
  Clinical Trial Update: Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma [Phase 3]

  Phase 3 trial investigating camrelizumab plus apatinib and temozolomide as first-line therapy for advanced acral melanoma is currently recru…

• CLINICAL_TRIALS trial_result · 2023-03-09
  Clinical Trial Update: The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery [Phase 3]

  Phase 3 trial evaluating IBI310 in combination with IBI308 versus high-dose interferon in acral melanoma that has been removed by surgery; s…

• CLINICAL_TRIALS trial_result · 2016-12-08
  Clinical Trial Update: Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma [Phase 2]

  Phase 2 trial evaluating nilotinib in patients with metastatic mucosal, acral, or chronically sun-damaged melanoma who are resistant or into…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.